A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this open-label, single dose, two-treatment, two-period, cross-over study is to evaluate the pharmacokinetic profile and tolerability of galantamine oral solution and galantamine tablet.
Epistemonikos ID: 1c24db478adac0a1e9cbf908a948f59e5f30ac84
First added on: May 04, 2024